Brief: Hepion Pharmaceuticals Says On July 21 Entered Into Controlled Equity Offering Sales Agreement With Cantor Fitzgerald & Co As Sales Agent
21/07/2023 21:46
July 21 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O :
* HEPION PHARMACEUTICALS - ON JULY 21 ENTERED INTO
CONTROLLED
EQUITY OFFERING(SM)SALES AGREEMENT WITH CANTOR FITZGERALD & CO.
AS SALES AGENT
* HEPION PHARMACEUTICALS - PURSUANT TO AGREEMENT CO MAY
OFFER AND
SELL SHARES OF CO'S COMMON STOCK HAVING AGGREGATE OFFERING PRICE
OF UP TO $24 MILLION
Further company coverage: HEPA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Hepion Pharmaceuticals
See all newsBrief: Hepion Pharmaceuticals Executes Binding Letter Of Intent With New Day Diagnostics To Commercialize Diagnostic Tests For Celiac Disease, Respiratory Multiplex, H. Pylori And Hcc
Brief: Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing
Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
Brief: Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement